February 3, 2022
A bill to legalize a pharmaceutical derivative of marijuana is moving through the Legislature. House Bill (HB) 446, which legalizes nabiximols — medications treating neuropathic pain for multiple sclerosis sufferers — upon Federal Drug Administration approval, passed the House on Jan. 31.
But what about the broader issue of medical marijuana?
“Right now, we are at about 6,000 …
Enter your email address/USER ID and password in the fields above to gain access to the subscriber content on this site.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time. To inquire about group subscriptions for your organization, contact Shaun Witt.
Already a paid subscriber but not registered for online access yet? Click Here to register.